Combination Bacillus Calmette-Guérin and indoleamine 2,3-dioxygenase 1 inhibitor therapy of murine orthotopic bladder cancer-Reference-Cited by-同舟云学术

Combination Bacillus Calmette-Guérin and indoleamine 2,3-dioxygenase 1 inhibitor therapy of murine orthotopic bladder cancer

Published:2020-08-29 Issue:5 Volume:126 Page:554-556
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Lee Sze Han¹,Mahendran Ratha²,Tham Sin Mun²³,Thamboo Thomas Paulraj⁴,Kioh Dorinda Yan Qin¹,Tang Lloyd Wei Tat¹,Chiong Edmund²³,Esuvaranathan Kesavan²³,Chan Eric Chun Yong¹^ORCID

Affiliation:

1. Department of Pharmacy; National University of Singapore; Singapore City Singapore

2. Department of Surgery; National University of Singapore; Singapore City Singapore

3. Department of Urology; National University Hospital; Singapore City Singapore

4. Department of Pathology; National University Hospital; Singapore City Singapore

Funder

National University Health System (NUHS) Innovation Grant

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.15201/fullpdf

Reference7 articles.

1. Management of BCG failures in superficial bladder cancer: a review;Witjes;Eur Urol,2006

2. Role of Th1 and Th2 cytokines in BCG-induced IFN-γ production: cytokine promotion and simulation of BCG effect;Luo;Cytokine,2003

3. Targeting the IDO1/TDO2-KYN-AhR pathway for cancer immunotherapy - challenges and opportunities;Cheong;Trends Pharmacol Sci,2018

4. A murine orthotopic bladder tumor model and tumor detection system;Tham;J Vis Exp,2017

5. Bacille-Calmette-Guerin non-responders: how to manage;Von Rundstedt;Transl Androl Urol,2015

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pre-clinical investigation of STAT3 pathway in bladder cancer: Paving the way for clinical translation;Biomedicine & Pharmacotherapy;2021-01